Publicaciones
...menos
1. Noguez Imm R, Muñoz-Benitez J, Medina D, Barcenas E, Molero-Castillo G, Reyes-Ortega P, Hughes-Cano JA, Medrano-Gracia L, Miranda-Anaya M, Rojas-Piloni G, Quiroz-Mercado H, Hernández-Zimbrón LF, Fajardo-Cruz ED, Ferreyra-Severo E, García-Franco R, Rubio Mijangos JF, López-Star E, García-Roa M, Lansingh VC, and Thébault SC , Preventable risk factors for type 2 diabetes can be detected using noninvasive spontaneous electroretinogram signals, Plos One, enero de 2023; 1(18)
2. Ramsés Noguez Imm, Julio Muñoz-Benitez, Diego Medina, Everardo Barcenas, Guillermo Molero-Castillo, Pamela Reyes-Ortega, Jorge Armando Hughes-Cano, Leticia Medrano-Gracia, Manuel Miranda-Anaya, Gerardo Rojas-Piloni, Hugo Quiroz-Mercado, Luis Fernando Hernández-Zimbrón, Elisa Denisse Fajardo-Cruz, Ezequiel Ferreyra-Severo, Renata García-Franco, Ellery López-Star, Marlon García-Roa, Van Charles Lansingh, Stéphanie C. Thébault, Spontaneous electroretinogram signals to screen people with early risk factors for diabetic retinopathy, MedRxiv, noviembre de 2022
3. Stéphanie Thébault, Minireview: Insights into the role of TRP channels in the retinal circulation and function, Neuroscience Letters, noviembre de 2020; 765(136285)
4. Edith Arnold*, Stéphanie Thébault*, Rodrigo M. Aroña*(*co-autoria), Gonzalo Martínez de la Escalera, Carmen Clapp, Prolactin mitigates deficiencies of retinal function associated with aging, Neurobiology of Aging, octubre de 2019; 85, 38-48
5. Orduña Ríos M, Noguez Imm R, Hernández Godínez N, Bautista Cortes AM, Liedtke W, Martínez-Torres A, Concha L, Thebault S , TRPV4 inhibition prevents increased water diffusion and blood-retina barrier breakdown in the retinal of streptozotocin-induced diabetic mice, Plos One, mayo de 2019; 14(5), e0212158
6. Arredondo Zamarripa D*, Noguez Imm R* (*co-autoria), Bautista Cortés AM, Vázquez Ruíz O, Bernardini M, Fiorio Pla A, Gkika D, Prevarskaya N, López-Casillas F, Liedtke W, Clapp C, and Thebault S , Dual contribution of TRPV4 antagonism in the regulatory effect of vasoinhibins on blood-retinal barrier permeability: diabetic milieu makes a difference. , Scientific Reports, octubre de 2017; 7(1), 13094
7. Thebault S, Potential mechanisms behind the antioxidant actions of prolactin in the retina, Experimental Eye Research, julio de 2017; 160, 56-61
8. Meléndez García R*, Arredondo Zamarripa R*, Arnold E* (*, equal contribution), Ruiz-Herrera X, Noguez Imm R, Baeza Cruz G, Adán N, Binart N, Riesgo-Escovar N, Goffin V, Ordaz B, Peña-Ortega F, Martínez-Torres A, Clapp C, and Thebault S, Prolactin protects retinal pigment epithelium by inhibiting SIRT2-dependent cell death, EBioMedicine, abril de 2016; 7, 35-49
9. Arredondo Zamarripa D, Díaz-Lezama N, Meléndez García R, Clapp C, and Thebault S (autor de correspondencia), Vasoinhibins regulate the inner and outer blood-retinal barrier and limit retinal oxidative stress, Frontiers in Cellular Neuroscience, octubre de 2014; 8(333)
10. Arnold E*, Thebault S* (*co-autoria; autor de correspondencia), Baeza-Cruz G, Arredondo Zamarripa D, Adán N, Quintanar-Stéphano A, Condés-Lara M, Rojas-Piloni G, Binart N, Martínez de la Escalera G, and Clapp C., The hormone prolactin is a novel, endogenous trophic factor able to regulate reactive glia and to limit retinal degeneration., Journal Of Neuroscience, junio de 2014; 34(5), 1868-78
11. Thebault S, El epitelio pigmentario retiniano como componente de la barrera hematoretiniana: implicación en la retinopatía diabética, Revista Digital Universitaria, junio de 2011; 12(3), 00-10
online
12. Clapp C, Thebault S, Jeziorski MC, and Martínez de la Escalera G. , Peptide hormone regulation of angiogenesis, Physiological Reviews, junio de 2009; 89(4), 1177-215
13. García, C., Aranda, J., Arnold, E., Thebault, S., Macotela, J., López-Casillas, F., Mendoza, V., Quiroz-Mercado, H., Lin, S.H., Martínez de la Escalera, G., Clapp, C., Vasoinhibins prevent increased retinal vasopermeability associated with diabetic retinopathy via protein phosphatase 2A-dependent eNOS inactivation, Journal Of Clinical Investigation, junio de 2008; 118(6), 2291-2300
14. Rivera, J.C., Aranda, J., Riesgo, J., Nava, G., Thebault, S., López-Barrera, F., Ramírez, M., Martínez de la Escalera, G., Clapp, C, Expression and cellular localization of prolactin and the prolactin receptor in mammalian retina., Experimental Eye Research, junio de 2008; 86(2), 314-321
15. Tiel Groenestege WM, Thebault S, van den Berg D, Janssen R, Tejpar S, van den Heuvel LP, van Cutsem E, Hoenderop JG, Knoers NV and Bindels RJ, Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia, Journal Of Clinical Investigation, junio de 2007; 117(8), 2260-2267
16. Thebault S, Flourakis M, Vanoverberghe K, Vandermoere F, Roudbaraki M, Lehen´kyi V, Slomianny C, Beck B, Mariot P, Bonnal JL, Mauroy B, Shuba Y, Capiod T, Skryma R, Prevarskaya N., Differential role of transient receptor potential channels in Ca2+ entry and proliferation of prostate cancer epithelial cells, Cancer Research, junio de 2006; 66(4), 2038-2047
17. Thebault S (autor de correspondencia), Zholos A, Enfissi A, Slomianny C, Dewailly E, Roudbaraki M, Parys J, Prevarskaya N., Receptor-operated Ca2+ entry mediated by TRPC3/TRPC6 proteins in rat prostate smooth muscle (PS1) cell line, Journal Of Cellular Physiology, junio de 2005; 204(1), 320-328
18. Thebault S, Lemonnier L, Bidaux G, Flourakis M, Bavencoffe A, Gordienko D, Roudbaraki M, Delcourt P, Panchin Y, Shuba Y, Skryma R, Prevarskaya N., Novel role of cold/menthol-sensitive transient receptor potential melastatine family member 8 (TRPM8) in the activation of store-operated channels in LNCaP human prostate cancer epithelial cells., Journal Of Biological Chemistry, junio de 2005; 280(47), 39423-39435
19. Thebault S, Roudbaraki M, Sydorenko V, Shuba Y, Lemonnier L, Slomianny C, Dewailly E, Bonnal JL, Mauroy B, Skryma R, Prevarskaya N., Alpha1-adrenergic receptors activate Ca(2+)-permeable cationic channels in prostate cancer epithelial cells, Journal Of Clinical Investigation, junio de 2003; 111(11), 1691-1701
20. Epardo D, Balderas-Márquez J, Rodríguez-Arzate C, Thébault SC, Carranza M, Luna M, Ávila-Mendoza J, Calderón-Vallejo D, Quintanar J, Arámburo C, and Martínez-Moreno C, Growth hormone (GH) promotes axonal growth and maintains retinal function after an optic nerve crush (ONC) in the male rat, Investigative Ophthalmology & Visual Science, septiembre de 2024; 7
21. Thébault SC, Tremblay M-E, Conde SV, González-González M.A, Editorial: Women in neuroscience of Bioelectronic Medicine, Frontiers in Integrative Neuroscience, abril de 2024; 18
22. Hughes-Cano JA, Quiroz-Mercado H, Hernández-Zimbrón LF, García-Franco R, Rubio Mijangos JF, López-Star E, García-Roa M, Lansingh VC, Olivares-Pinto U, Thébault SC, Improved predictive diagnosis of diabetic macular edema based on hybrid models: an observational study, Computers in Biology and Medicine, marzo de 2024; 170
23. Gonzalez-Gonzalez MA, Conde SV, Latorre R, Thébault SC, Pratelli M, Spitzer NC, Verkhratsky A, Tremblay ME, Akcora CG, Hernandez-Reynoso AG, Ecker M, Coates J, Vincent KL, Ma B, Bioelectronic medicine: a multidisciplinary roadmap from biophysics to precision therapies, Frontiers in Integrative Neuroscience, enero de 2024; 18
24. Pamela Reyes-Ortega, Alejandra Rodríguez-Arzate, Ramsés Noguez-Imm, Edith Arnold, and Stéphanie C. Thébault, Contribution of chemical and electrical transmission to the low delta-like intrinsic retinal oscillation in mice: a role for day-light activated neuromodulators , European Journal Of Pharmacology, enero de 2024; 968
25. Rodríguez-Arzate CA, Noguez-Imm R, Reyes-Ortega P, Rodríguez-Ortiz LR, García-Peña MF, Ordaz RP, Vélez-Uriza F, Cisneros-Mejorado A, Arellano RO, Perez CI, Hernández-Zimbrón LF, Hughes-Cano JA, Quiroz-Mercado H, García-Franco R, Rubio Mijangos JF, López-Star E, García-Roa E, Lansingh VC, Dégardin J, Simonutti M, Picaud D, and Thébault SC, Potential contributions of the intrinsic retinal oscillation recording using non-invasive electroretinogram to bioelectronics., Frontiers in Cellular Neuroscience, enero de 2024; 8(17)
26. JA Hughes-Cano, H Quiroz-Mercado, LF Hernández-Zimbrón, R García-Franco, JF Rubio Mijangos, E López-Star, M García-Roa, VC Lansingh, U Olivares-Pinto, Thebault SC. , Improved predictive diagnosis of diabetic macular edema based on hybrid models: an observational study, MedRxiv, enero de 2023
27. Lázaro-Guevara J.M., Flores- Robles B-J, Garrido-Lopez K.M., Labrador-Sánchez E., Pinillos-Aransay V., Trasahedo E.A., López-Martín J-A., Tellez-Arreola J.L., Thebault SC (corresponding author), Identification of RP1 as the genetic cause of retinitis pigmentosa in a multi-generational pedigree using Extremely Low-Coverage Whole Genome Sequencing (XLC-WGS), GENE, enero de 2023
28. Benítez-Angeles M., Juárez-González E., Vergara-Jaque A., Llorente I., Rangel-Yescas G., Thébault S.C. Hiriart M., Islas L.D., Rosenbaum T. , Unconventional interactions of the TRPV4 ion channel with beta-adrenergic receptor ligands, Life Science Alliance, diciembre de 2022
29. Thebault S, Pérdida de visión por diabetes: detección y tratamiento, Revista Digital Universitaria, mayo de 2019; 20(3)
30. Thebault S, Una luz frente a la pérdida de visión por diabetes, Revista Digital Universitaria, septiembre de 2018; 19(5)
31. David Arredondo Zamarripa, Ramsés Noguez Imm, Dulce María Soría Lara, Alessandra Fiorio Pla, Dimitra Gkika, Natalia Prevarskaya, Ataúlfo Martínez-Torres, Wolfang Liedtke, Carmen Clapp, and Stéphanie Thebault., Dual contribution of TRPV4 antagonism in the regulatory effect of vasoinhibins on blood-retinal barrier permeability: diabetic milieu makes a difference., Scientific Reports, diciembre de 2017; 7(1), 13094
32. Thebault S, Potential mechanisms behind the antioxidant actions of prolactin in the retina, Experimental Eye Research, diciembre de 2017; (160), 56-61
33. Zamorano M, Ledesma-Colunga MG, Adán N, Vera-Massieu C, Lemini M, Méndez I, Moreno-Carranza B, Neumann ID, Thebault S, Martínez de la Escalera G, Torner L, and Clapp C. , Prolactin-derived vasoinhibins increase anxiety- and depression-related behaviors., Psychoneuroendocrinology, junio de 2014; 44, 123-32
34. García, C., Nuñez-Arita, R.E., Thebault, S. (autor de correspondencia), Arredondo-Zamarripa, D., Jeziorski, M.C., Martínez de la Escalera, G., Clapp, C. , Requirement of phosphorytable endothelial nitric oxide synthase at Ser-1177 for vasoinhibin-mediated antiangiogenic effects, Endocrine, marzo de 2014; 45(2), 263-270
35. Adan N, Guzman-Morales J, Ledesma-Colunga G, Perales-Canales SI, Quintanar-Stephano A, Lopez-Barrera F, Mendez I, Moreno-Carranza B, Triebel J, Binart N, Martínez de la Escalera G, Thebault S, and Clapp C, Prolactin promotes cartilage survival and attenuates inflammation in rheumatoid arthritis., Journal Of Clinical Investigation, septiembre de 2013; 123(9), 3902-13
36. Vanoverberghe K*, Lehen'kyi V*, Thébault S* (*, de igual contribución), Raphaël M, Vanden Abeele F, Slomianny C, Mariot P, Prevarskaya N., Cytoskeleton reorganization as an alternative mechanism of store-operated calcium entry control in neuroendocrine-differentiated cells, Plos One, diciembre de 2012; 9(9), e45615
37. Thebault S* (autor de correspondencia), González C* (*, de igual contribución), García C, Arredondo Zamarripa D, Nava G, Vaca L, López-Casillas F, Martinez de la Escalera G, Clapp C., Vasoinhibins Prevent Bradykinin-Stimulated Endothelial Cell Proliferation by Inactivating eNOS via Reduction of both Intracellular Ca2+ Levels and eNOS Phosphorylation at Ser1179., Pharmaceuticals, diciembre de 2011; (4), 1052-1069
38. Vega C, Moreno-Carranza B, Zamorano M, Quintanar-Stephano A, Méndez I, Thebault S, Martinez de la Escalera G, Clapp C., Prolactin promotes oxytocin and vasopressin release by activating neuronal nitric oxide synthase in the supraoptic and paraventricular nuclei., AMERICAN JOURNAL OF PHYSIOLOGY: Regulatory, Integrative and Comparative Physiology, octubre de 2010; 299(6), R1701-8
39. Arnold E, Rivera JC, Thebault S, Moreno-Páramo D, Quiroz-Mercado H, Quintanar-Stéphano A, Binart N, de la Escalera GM, Clapp C, High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins. , Diabetes, agosto de 2010; 59(12), 3192-7
40. Castilla A, García C, Cruz-Soto M, Martínez de la Escalera G, Thebault S (autor de correspondencia), and Clapp C. , Prolactin in ovarian follicular fluid stimulates endothelial cell proliferation., Journal of Vascular Research, diciembre de 2009; 47(1), 45-53
41. Cruz-Soto ME, Cosío G, Jeziorski MC, Vargas-Barroso V, Aguilar MB, Cárabez A, Berger P, Saftig P, Arnold E, Thebault S, Martínez de la Escalera G, and Clapp C. , Cathepsin D is the primary protease for the generation of adenohypophyseal vasoinhibins: Cleavage occurs within the prolactin secretory granules., Endocrinology, diciembre de 2009; 150(12), 5446-54
42. Thebault S, Alexander RT, Tiel Groenestege WM, Hoenderop JG, Bindels RJ., EGF increases TRPM6 activity and surface expression, Journal of the American Society of Nephrology, enero de 2009; 20(1), 78-85
43. Cao G*, Thébault S* (*, de igual contribución), van der Wijst J, van der Kemp A, Lasonder E, Bindels RJ, Hoenderop JG., RACK1 Inhibits TRPM6 Activity via Phosphorylation of the Fused alpha-Kinase Domain, Current Biology, diciembre de 2008; 18(3), 168-176
44. Clapp C, Thebault S, Arnold E, García C, Rivera JC, Martínez de la Escalera G., Vasoinhibins: Novel inhibitors of ocular angiogenesis, American Journal Of Physiology, Endocrinology And Metabolism, octubre de 2008; 295(4), 772-778
45. Thébault S, Cao G, Venselaar H, Xi Q, Bindels RJ, Hoenderop JG., Role of the alpha-kinase domain in TRPM6 channel and regulation by intracellular ATP, Journal Of Biological Chemistry, mayo de 2008; 283(29), 19999-20007
46. Clapp, C., Thebault, S, Martínez de la Escalera, G., Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland., Journal Of Mammary Gland Biology And Neoplasia, marzo de 2008; 13(1), 55-67
47. Clapp C., Thebault S., Martínez de la Escalera G., Hormones and postpartum cardiomyopathy, Trends In Endocrinology And Metabolism, noviembre de 2007; 18(9), 329-330
48. Bidaux G, Flourakis M, Thebault S, Zholos A, Beck B, Roudbaraki M, Bonnal JL, Mauroy B, Shuba Y, Skryma R and Prevarskaya N, . Differentation status of prostate cells determines TRPM8 channel subcellular localization and function: involvement in carcinogenesis, Journal Of Clinical Investigation, junio de 2007; 117(6), 1647-1657
49. Topala CN, Tiel-Groenestege W, Thebault S, van den Berg D, Nilius B, Hoenderop JGJ, Bindels R., Molecular determinants of permeation through the cation channel TRPM6, Cell Calcium, junio de 2007; 41(6), 513-523
50. Beck B, Bidaux G, Bavencoffe A, Lemonnier L, Thebault S, Shuba Y, Barrit G, Skryma R, Prevarskaya N., Prospects for prostate cancer imaging and therapy using high-affinity TRPM8 activators, Cell Calcium, marzo de 2007; 41(3), 285-294
51. Prevarskaya N, Flourakis M, Bidaux G, Thebault S, Skryma R., Differential role of TRP channels in prostate cancer, Biochemical Society Transactions, febrero de 2007; 35(1), 133-135
52. Vanden Abeele F, Zholos A, Bidaux G, Shuba Y, Thebault S, Beck B, Flourakis M, Panchin Y, Skryma R, Prevarskaya N., iPLA2-dependent gating of TRPM8 by lysophospholipids., Journal Of Biological Chemistry, diciembre de 2006; 281(52), 40174-40182
53. Gkika D, Topala CN, Chang Q, Picard N, Thebault S, Houillier P, Hoenderop JG and Bindels RJM., Tissue kallikrein stimulates Ca2+ reabsorption via PKC-dependent plasma membrane accumulation of TRPV5, Embo Journal, octubre de 2006; 25(20), 4707-4716
54. Thebault S, Hoenderop JG, Bindels RJ, Epithelial Ca2+ and Mg2+ channels in kidney disease, Advances In Chronic Kidney Disease, abril de 2006; 13(2), 110-117
55. Bidaux G, Roudbaraki M, Merle C, Crepin A, Delcourt P, Slomianny C, Thebault S, Bonnal JL, Benahmed M, Cabon F, Mauroy B, Prevarskaya N., Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement, Endocrine-Related Cancer, junio de 2005; 12(2), 367-382
56. Lemonnier L, Lazarenko R, Shuba Y, Thebault S, Roudbaraki M, Lepage G, Prevarskaya N, Skryma R., Alterations in the regulatory volume decrease (RVD) and swelling-activated Cl- current associated with neuroendocrine differentiation of prostate cancer epithelial cells, Endocrine-Related Cancer, junio de 2005; 12(2), 335-349
57. Vanden Abeele F, Lemonnier L, Thebault S, Lepage G, Parys JB, Shuba Y, Skryma R, Prevarskaya N., Two types of store-operated Ca2+ channels with different activation modes and molecular origin in LNCaP human prostate cancer epithelial cells, Journal Of Biological Chemistry, julio de 2004; 279(29), 30326-30337
58. Sydorenko V, Shuba Y, Thebault S, Roudbaraki M, Lepage G, Prevarskaya N, Skryma R., Receptor-coupled, DAG-gated Ca2+-permeable cationic channels in LNCaP human prostate cancer epithelial cells, Journal Of Physiology-London, mayo de 2003; 548(3), 823-836